Clearstead Trust, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Clearstead Trust, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$8,958
+8.3%
1000.0%0.00%0.0%
Q2 2023$8,2750.0%1000.0%0.00%0.0%
Q1 2023$8,275
+103337.5%
1000.0%0.00%0.0%
Q4 2022$8
-99.9%
1000.0%0.00%
+50.0%
Q3 2022$7,0000.0%1000.0%0.00%
-60.0%
Q2 2022$7,000
+16.7%
1000.0%0.01%
+25.0%
Q1 2022$6,000
+20.0%
1000.0%0.00%
+33.3%
Q4 2021$5,000
-28.6%
1000.0%0.00%
-25.0%
Q3 2021$7,0000.0%1000.0%0.00%
-20.0%
Q2 2021$7,0001000.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders